David Hoang
Stock Analyst at Deutsche Bank
(1.95)
# 3,108
Out of 4,905 analysts
41
Total ratings
41.94%
Success rate
-7.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Hoang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $54 → $55 | $35.20 | +56.25% | 3 | Jul 10, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Hold | $50 → $25 | $14.08 | +77.62% | 7 | Jun 17, 2025 | |
| ACAD ACADIA Pharmaceuticals | Upgrades: Buy | $20 → $35 | $22.56 | +55.14% | 5 | May 21, 2025 | |
| ALKS Alkermes | Maintains: Buy | $40 → $52 | $29.22 | +77.96% | 2 | Mar 27, 2025 | |
| XENE Xenon Pharmaceuticals | Initiates: Buy | $67 | $31.59 | +112.09% | 3 | Feb 11, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $111 | $53.85 | +106.13% | 1 | Feb 11, 2025 | |
| DNLI Denali Therapeutics | Initiates: Buy | $31 | $14.00 | +121.43% | 3 | Feb 11, 2025 | |
| BHVN Biohaven | Initiates: Buy | $65 | $14.05 | +362.63% | 1 | Feb 11, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $176 | $111.70 | +57.56% | 4 | Feb 11, 2025 | |
| AVDL Avadel Pharmaceuticals | Initiates: Buy | $12 | $10.83 | +10.80% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $150 → $158 | $132.02 | +19.68% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.50 | +366.67% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $8 | $9.12 | -12.23% | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.39 | +150.39% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $3.24 | +393.83% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $220 | $320.53 | -31.36% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $80 | $16.76 | +377.33% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 | $1.70 | +76.47% | 1 | Dec 7, 2022 |
Harmony Biosciences Holdings
Jul 10, 2025
Maintains: Buy
Price Target: $54 → $55
Current: $35.20
Upside: +56.25%
Sarepta Therapeutics
Jun 17, 2025
Maintains: Hold
Price Target: $50 → $25
Current: $14.08
Upside: +77.62%
ACADIA Pharmaceuticals
May 21, 2025
Upgrades: Buy
Price Target: $20 → $35
Current: $22.56
Upside: +55.14%
Alkermes
Mar 27, 2025
Maintains: Buy
Price Target: $40 → $52
Current: $29.22
Upside: +77.96%
Xenon Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $67
Current: $31.59
Upside: +112.09%
Praxis Precision Medicines
Feb 11, 2025
Initiates: Buy
Price Target: $111
Current: $53.85
Upside: +106.13%
Denali Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $31
Current: $14.00
Upside: +121.43%
Biohaven
Feb 11, 2025
Initiates: Buy
Price Target: $65
Current: $14.05
Upside: +362.63%
Axsome Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $176
Current: $111.70
Upside: +57.56%
Avadel Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $12
Current: $10.83
Upside: +10.80%
Aug 2, 2024
Maintains: Neutral
Price Target: $150 → $158
Current: $132.02
Upside: +19.68%
Jul 25, 2024
Initiates: Buy
Price Target: $7
Current: $1.50
Upside: +366.67%
May 29, 2024
Initiates: Sell
Price Target: $8
Current: $9.12
Upside: -12.23%
Mar 15, 2024
Initiates: Buy
Price Target: $16
Current: $6.39
Upside: +150.39%
Mar 7, 2024
Initiates: Buy
Price Target: $16
Current: $3.24
Upside: +393.83%
Apr 26, 2023
Initiates: Neutral
Price Target: $220
Current: $320.53
Upside: -31.36%
Apr 26, 2023
Initiates: Outperform
Price Target: $80
Current: $16.76
Upside: +377.33%
Dec 7, 2022
Downgrades: Neutral
Price Target: $3
Current: $1.70
Upside: +76.47%